Ipratropium Bromide and Albuterol Sulfate (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Ipratropium Bromide and Albuterol Sulfate drug offered from Actavis Pharma, Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | ipratropium bromide and albuterol sulfate |
| SUBSTANCE NAME: | IPRATROPIUM BROMIDE; ALBUTEROL SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-05-13 |
| END MARKETING DATE: | 0000-00-00 |
Ipratropium Bromide and Albuterol Sulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ipratropium Bromide and Albuterol Sulfate from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .5; 2.5(mg/3mL; mg/3mL) |
| START MARKETING DATE: | 2013-05-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3817_aa91893b-eee3-4ecc-a00e-275937628328 |
| PRODUCT NDC: | 0591-3817 |
| APPLICATION NUMBER: | ANDA202496 |
Other IPRATROPIUM BROMIDE; ALBUTEROL SULFATE Pharmaceutical Manufacturers / Labelers:
